Astellas’ Betmiga (mirabegron)
for overactive bladder syndrome,
Pfizer’s Prevenar 13 (13-valent
pneumococcal conjugate vaccine)
and Bayer’s Stivarga for metastatic
colorectal cancer have been added
to the Australian Public Assessment
Reports for prescription medicines
(AusPARs).
CLICK HERE to access the full
details posted by the Therapeutic
Goods Administration.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Feb 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Feb 14
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.